KYTX
Price
$3.39
Change
+$0.45 (+15.31%)
Updated
Jun 6 closing price
Capitalization
146.51M
72 days until earnings call
MGX
Price
$1.73
Change
+$0.07 (+4.22%)
Updated
Jun 6 closing price
Capitalization
64.67M
67 days until earnings call
Interact to see
Advertisement

KYTX vs MGX

Header iconKYTX vs MGX Comparison
Open Charts KYTX vs MGXBanner chart's image
Kyverna Therapeutics
Price$3.39
Change+$0.45 (+15.31%)
Volume$528.73K
Capitalization146.51M
Metagenomi
Price$1.73
Change+$0.07 (+4.22%)
Volume$502.12K
Capitalization64.67M
KYTX vs MGX Comparison Chart
Loading...
KYTX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
MGX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
KYTX vs. MGX commentary
Jun 07, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is KYTX is a Buy and MGX is a StrongBuy.

Interact to see
Advertisement
COMPARISON
Comparison
Jun 07, 2025
Stock price -- (KYTX: $3.39 vs. MGX: $1.73)
Brand notoriety: KYTX and MGX are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: KYTX: 167% vs. MGX: 150%
Market capitalization -- KYTX: $146.51M vs. MGX: $64.67M
KYTX [@Biotechnology] is valued at $146.51M. MGX’s [@Biotechnology] market capitalization is $64.67M. The market cap for tickers in the [@Biotechnology] industry ranges from $324.3B to $0. The average market capitalization across the [@Biotechnology] industry is $2.35B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

KYTX’s FA Score shows that 0 FA rating(s) are green whileMGX’s FA Score has 1 green FA rating(s).

  • KYTX’s FA Score: 0 green, 5 red.
  • MGX’s FA Score: 1 green, 4 red.
According to our system of comparison, MGX is a better buy in the long-term than KYTX.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

KYTX’s TA Score shows that 4 TA indicator(s) are bullish while MGX’s TA Score has 6 bullish TA indicator(s).

  • KYTX’s TA Score: 4 bullish, 3 bearish.
  • MGX’s TA Score: 6 bullish, 2 bearish.
According to our system of comparison, MGX is a better buy in the short-term than KYTX.

Price Growth

KYTX (@Biotechnology) experienced а +32.94% price change this week, while MGX (@Biotechnology) price change was +1.76% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +9.04%. For the same industry, the average monthly price growth was +14.90%, and the average quarterly price growth was +1.90%.

Reported Earning Dates

KYTX is expected to report earnings on Aug 18, 2025.

MGX is expected to report earnings on Aug 13, 2025.

Industries' Descriptions

@Biotechnology (+9.04% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
KYTX($147M) has a higher market cap than MGX($64.7M). KYTX YTD gains are higher at: -9.358 vs. MGX (-52.078). MGX has higher annual earnings (EBITDA): -65.06M vs. KYTX (-108.46M). KYTX has more cash in the bank: 322M vs. MGX (275M). KYTX has less debt than MGX: KYTX (9.14M) vs MGX (46.1M). MGX has higher revenues than KYTX: MGX (55.1M) vs KYTX (0).
KYTXMGXKYTX / MGX
Capitalization147M64.7M227%
EBITDA-108.46M-65.06M167%
Gain YTD-9.358-52.07818%
P/E RatioN/AN/A-
Revenue055.1M-
Total Cash322M275M117%
Total Debt9.14M46.1M20%
TECHNICAL ANALYSIS
Technical Analysis
KYTXMGX
RSI
ODDS (%)
Bearish Trend 2 days ago
90%
N/A
Stochastic
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
90%
Momentum
ODDS (%)
Bullish Trend 2 days ago
75%
Bullish Trend 2 days ago
68%
MACD
ODDS (%)
N/A
Bullish Trend 2 days ago
78%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
73%
Bullish Trend 2 days ago
78%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
70%
Bullish Trend 2 days ago
84%
Advances
ODDS (%)
Bullish Trend 2 days ago
80%
Bullish Trend 5 days ago
78%
Declines
ODDS (%)
N/A
Bearish Trend 3 days ago
90%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
90%
N/A
Aroon
ODDS (%)
N/A
Bullish Trend 2 days ago
90%
View a ticker or compare two or three
Interact to see
Advertisement
KYTX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
MGX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
FCUPX19.200.14
+0.73%
NYLI PineStone U.S. Equity Class P
IBARX24.330.08
+0.33%
Macquarie Balanced Fund Class R6
HSMYX12.16N/A
N/A
Hartford Small Cap Value Y
HEQCX5.32N/A
N/A
Monteagle Opportunity Equity Instl
BTEKX75.46N/A
N/A
BlackRock Technology Opportunities K

KYTX and

Correlation & Price change

A.I.dvisor indicates that over the last year, KYTX has been loosely correlated with IMNM. These tickers have moved in lockstep 47% of the time. This A.I.-generated data suggests there is some statistical probability that if KYTX jumps, then IMNM could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To KYTX
1D Price
Change %
KYTX100%
+15.31%
IMNM - KYTX
47%
Loosely correlated
+0.11%
CABA - KYTX
47%
Loosely correlated
+13.76%
CRSP - KYTX
45%
Loosely correlated
+8.53%
IPSC - KYTX
45%
Loosely correlated
+9.47%
TRDA - KYTX
44%
Loosely correlated
+2.46%
More

MGX and

Correlation & Price change

A.I.dvisor indicates that over the last year, MGX has been loosely correlated with KOD. These tickers have moved in lockstep 42% of the time. This A.I.-generated data suggests there is some statistical probability that if MGX jumps, then KOD could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To MGX
1D Price
Change %
MGX100%
+4.22%
KOD - MGX
42%
Loosely correlated
+7.65%
VERV - MGX
38%
Loosely correlated
+8.12%
KYTX - MGX
35%
Loosely correlated
+15.31%
IMNM - MGX
35%
Loosely correlated
+0.11%
CVM - MGX
33%
Poorly correlated
+0.85%
More